Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies. [electronic resource]
Producer: 20060901Description: 413-21 p. digitalISSN:- 0167-6997
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Doxorubicin -- administration & dosage
- Female
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasms -- drug therapy
- Neutropenia -- chemically induced
- Thrombocytopenia -- chemically induced
- Topotecan -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.